Early data from a clinical study suggest that blocking Bruton tyrosine kinase (BTK) provides clinical benefits for a small group of patients with severe COVID-19. The researchers responsible for the study observed […]
A total of seven new small molecule kinase inhibitors have been approved by FDA in 2017. Protein kinases form a very large family of signaling proteins, with more than 500 […]